FINWIRES · TerminalLIVE
FINWIRES

$VALN

5 stories mentioning VALNUpdated 40d ago

Every FINWIRES story that references VALN, newest first.

What are analysts saying about VALN?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on VALN?

Sectors

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.5%.The iShares Biotechnology ETF (IBB) lost 0.5%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. UnitedHealth shares were up 0.8%.Valneva (VALN) shares jumped 25% after the company and Pfizer (PFE) said the European Medicines Agency validated their marketing authorization application for their Lyme disease vaccine candidate, starting the regulatory review process. Pfizer shares were fractionally lower.Eton Pharmaceuticals (ETON) shares surged 41%. The company late Thursday reported Q2 adjusted earnings and revenue above market expectations and raised full-year 2026 sales guidance.Zentalis Pharmaceuticals (ZNTL) shares fell past 12% in Friday trading, a day after the company priced an offering of 23 million shares at $3.50 each, targeting about $80.5 million in gross proceeds.

$ETON$PFE$UNH$VALN$ZNTL
Wire

Sector Update: Healthcare Stocks Decline Friday Afternoon

Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.6%.The iShares Biotechnology ETF (IBB) lost 0.6%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. UnitedHealth shares were up 0.5%.Valneva (VALN) shares jumped 27% after the company and Pfizer (PFE) said the European Medicines Agency validated their marketing authorization application for their Lyme disease vaccine candidate, starting the regulatory review process. Pfizer shares were fractionally lower.Heartflow (HTFL) shares surged 33% after it posted a narrower Q2 non-GAAP loss, as revenue increased during the period, and raised its 2026 revenue outlook.

$HTFL$PFE$UNH$VALN
Sectors

Sector Update: Healthcare Stocks Flat to Lower Pre-Bell Friday

Healthcare stocks were flat to lower pre-bell Friday, with the iShares Biotechnology ETF (IBB) unchanged and the State Street Health Care Select Sector SPDR ETF (XLV) declining by 0.2%.Heartflow (HTFL) stock was up nearly 24% after the company posted a narrower Q2 non-GAAP loss, as revenue increased during the period, and raised its 2026 revenue outlook.Valneva (VALN) shares were up nearly 26% after the company and Pfizer (PFE) said the European Medicines Agency validated their marketing authorization application for their Lyme disease vaccine candidate, starting the regulatory review process. Pfizer stock was 0.1% lower premarket.Capricor Therapeutics (CAPR) shares were up more than 85% after the company said the US Food and Drug Administration is willing to review an amendment to its biologics license application for deramiocel, potentially shifting the drug's focus to upper-limb skeletal muscle function in Duchenne muscular dystrophy.

$CAPR$HTFL$IBB$PFE$VALN$XLV
Research

TD Cowen Initiates Valneva at Buy Rating, With $12 Price Target

Valneva SE (VALN) has an average rating of buy and mean price target of $12.12, according to analysts polled by FactSet.

$VALN
Research

Goldman Sachs Downgrades Valneva to Sell From Neutral, Adjusts Price Target to $4.90 From $7.50

Valneva SE (VALN) has an average rating of buy and mean price target of $13.60, according to analysts polled by FactSet.

$VALN

Track with the FINWIRES app suite